2010 Q2/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Neurimmune Therapeutics AG
9.0
2 +0 Lipideon Biotechnology AG
8.8
3 +5 Newron
8.2
4 -1 Medinova AG
8.1
5 +1 AmVac AG
7.2
6 +4 ArisGen SA
7.0
7 -3 OMIDA AG
6.9
8 +8 Arpida AG
6.9
9 +10 Johnson & Johnson Pharmaceutical Research & Development
6.8
10 +2 BioPartners GmbH
6.7
11 +54 F. Hoffmann-La Roche AG Global
6.7
12 +2 4-Antibody AG
6.7
13 -4 Alpex Pharma SA
6.6
14 +50 Antares Pharma AG
6.5
15 +9 Evolva SA
6.5
16 -3 Axenoll AG
6.5
17 -6 Siegfried AG
6.5
18 -1 Kuros Biosurgery AG
6.4
19 +12 Neurotune
6.4
20 +0 Tricom GmbH, Pharma Division
6.3
21 -6 Biogen Idec International GmbH
6.3
22 +0 Molecular Partners AG
6.2
23 +10 Vifor (International) Ltd.
6.1
24 +44 Nycomed International Management GmbH
6.0
25 +1 Anavex Life Sciences Corp.
5.9
26 +2 Max Zeller Söhne AG
5.9
27 +2 GKL Biotec AG
5.8
28 -7 BioVersys GmbH
5.8
29 -2 Auris Medical AG
5.8
30 +11 F. Hoffmann-La Roche AG Switzerland
5.7
31 -8 Helvepharm AG
5.7
32 +5 Addex Pharmaceuticals
5.6
33 -15 AC Immune SA
5.6
34 -29 Nycomed Pharma AG
5.6
35 -13 Cytos Biotechnology AG
5.2
36 +0 Axentis Pharma AG
5.2
37 +3 Lunamed AG
5.1
38 -2 Novartis International AG
5.0
39 -9 Basilea Pharmaceutica Ltd.
5.0
40 +21 Permamed AG
4.9
41 +1 Covagen AG
4.9
42 -3 Aurora Pharma GmbH
4.7
43 +6 Ergonex Pharma GmbH
4.6
44 -6 Ferring International Center SA
4.4
45 +0 Novo Nordisk Pharma AG
4.4
46 +1 Valeant Pharmaceuticals Switzerland GmbH
4.4
47 +1 Medipol SA
4.3
48 +7 PharmaSwiss SA - HQ
4.3
49 -15 CSL Behring AG
4.3
50 -25 Galenica Ltd.
4.3


Changes in rank are compared to 2010 Q1/Global Life Sciences. Since then, 3 sites entered the survey and 8 sites could not be included in the rankings (3 fewer since last time). Build your own. Report statistics.